Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation.

Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.

Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation.

Lancet. 1983 Jul 9;2(8341):78-81. Unique Identifier : AIDSLINE MED/83243577
Levy JA; Ziegler JL

Abstract: Two hypotheses are presented to explain the recent outbreak of acquired immunodeficiency syndrome (AIDS) and Kaposi's sarcoma in certain risk groups, particularly homosexuals, and the absence of these diseases from other segments of the population. According to the first, AIDS is itself an opportunistic infection. It causes disease only in individuals who are already immunocompromised by hepatitis B, cytomegalovirus, parasites, or other immunosuppressive factors. This hypothesis predicts that evidence of previous contact with the AIDS agent would be found in healthy individuals who have had the immune capability to suppress its pathogenicity. It also suggests that individuals with evidence of immunodeficiency are at risk of this syndrome and should adopt a lifestyle favouring recovery of their immune system. According to the second hypothesis, the high incidence of Kaposi's sarcoma observed in immunocompromised AIDS patients is not due to decreased immunosurveillance but to a reactive secretion of immunomodulating factors with angiogenesis-promoting activity. They are released in an attempt to bring the immune system back into balance. These factors would enhance capillary proliferation and subsequent transformation of endothelial cells, perhaps via cytomegalovirus.

Keywords: Acquired Immunodeficiency Syndrome/*ETIOLOGY/IMMUNOLOGY/ MICROBIOLOGY *Angiogenesis Factor/SECRETION Animal *Growth Substances/SECRETION Human Immunosuppression/*ADVERSE EFFECTS Models, Biological Pneumonia, Pneumocystis carinii/IMMUNOLOGY Risk Sarcoma, Kaposi's/*ETIOLOGY/IMMUNOLOGY/MICROBIOLOGY T-Lymphocytes, Helper-Inducer/ANALYSIS T-Lymphocytes, Suppressor-Effector/ANALYSIS Tumor Virus Infections/IMMUNOLOGY JOURNAL ARTICLE

831030
M83A0007

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1983. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1983. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .